… (erlotinib OR gefitinib) AND (controlled AND clinical trial). We selected all randomized studies
of erlotinib or gefitinib … The following study selection criteria were used: phase II and phase …

… trial results for erlotinib and gefitinib led to differences in regulatory policy, no head-to-head
randomised controlled trials … initiated a randomised controlled trial of erlotinib vs gefitinib in …

… of EGFR TKIs; instead, we have included only randomized controlled trials that compared
EGFR … This is because randomized controlled trials have a more stringent and consistent study …

… to assess as individual randomized clinical trials are not powered to detect a significant
relationship. Our study pooled data from 29 randomized clinical trials to overcome this limitation, …

… , a key aim of the erlotinib clinical trial program is to investigate erlotinib in combination with
… Moreover, in contrast to erlotinib, gefitinib is recommended for use below its monotherapy …

… As mentioned above, both randomized controlled trials and cohort studies were included
in this systematic review. The risk of bias in randomized controlled trials was assessed using …

… We did this randomised controlled trial in 52 Italian hospitals. … randomly assigned centrally
(1:1) to receive either erlotinib … to the EGFR tyrosine kinase inhibitors gefitinib and erlotinib. …

… Gefitinib was proven to be the better choice for advanced NSCLC, with equal antitumor …
AEs compared with erlotinib. Further large-scale, well-designed randomized controlled trials are …

… revealed superior PFS with osimertinib compared with first-generation EGFR TKIs (erlotinib
or gefitinib), and osimertinib has become the preferred first-line therapy. Consequently, there …

… (EGFR), such as erlotinib (Tarceva) and gefitinib (Iressa), have shown … randomized controlled
trial showing a survival benefit compared with placebo, erlotinib gained US Food and Drug …